North Dakota

presented by
Hospitals

‘Cross-kingdom’ vaccine may protect against fungal and bacterial infections

A clinical-stage pharmaceutical company with a vaccine it says uses a single antigen to protect against both fungal and bacterial infections is looking for a series B round to fund phase 2 trials for hospital-associated infection and women’s health applications next year. NovaDigm Therapeutics’ lead product, the NDV-3 vaccine, targets the fungal infection candida and […]